News
ATR
132.93
+0.91%
1.20
Weekly Report: what happened at ATR last week (0810-0814)?
Weekly Report · 2d ago
Dividend Champion, Contender, And Challenger Highlights: Week August 16
Seeking Alpha · 5d ago
WST Gains 15.3% in Three Months as HVP Growth Strengthens Outlook
NASDAQ · 6d ago
The Bull Case For AptarGroup (ATR) Could Change Following Rising Sales, Softer EPS And Buybacks
Simply Wall St · 08/12 15:33
Weekly Report: what happened at ATR last week (0803-0807)?
Weekly Report · 08/10 09:03
Is AptarGroup (ATR) Still Cheap As Sales Rise But Earnings Slip?
Simply Wall St · 08/06 19:38
Top AptarGroup Executive Makes Major Stock Move That Has Investors Talking
TipRanks · 08/06 02:12
President of Aptar Closures Of AptarGroup Sold 37% Of Their Shares
Simply Wall St · 08/05 10:36
Top Executive Makes Major Move With AptarGroup Shares
TipRanks · 08/04 02:03
AptarGroup Is Maintained at Overweight by Wells Fargo
Dow Jones · 08/03 14:39
AptarGroup Price Target Raised to $155.00/Share From $145.00 by Wells Fargo
Dow Jones · 08/03 14:39
Wells Fargo Maintains Overweight on AptarGroup, Raises Price Target to $155
Benzinga · 08/03 14:29
Analysts Have Conflicting Sentiments on These Healthcare Companies: AptarGroup (ATR), Myriad Genetics (MYGN) and HCA Healthcare (HCA)
TipRanks · 08/03 11:00
Weekly Report: what happened at ATR last week (0727-0731)?
Weekly Report · 08/03 09:03
AptarGroup Earnings Call: Record Sales, Margin Squeeze
TipRanks · 08/01 00:08
AptarGroup (ATR) Stock Revenue Record Masks Broad Margin Compression
Simply Wall St · 07/31 22:34
AptarGroup price target lowered to $172 from $173 at BofA
TipRanks · 07/31 18:20
Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR), Mettler-Toledo (MTD) and Dexcom (DXCM)
TipRanks · 07/31 17:10
Analysts’ Opinions Are Mixed on These Healthcare Stocks: AptarGroup (ATR) and Contineum Therapeutics, Inc. Class A (CTNM)
TipRanks · 07/31 09:00
AptarGroup sees Q3 EPS $1.45-$1.53, consensus $1.46
TipRanks · 07/30 21:05
More
Webull provides a variety of real-time ATR stock news. You can receive the latest news about Aptargroup through multiple platforms. This information may help you make smarter investment decisions.
About ATR
AptarGroup, Inc. is engaged in the design and manufacturing of drug and consumer product dosing, dispensing, and protection technologies. The Company serves diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care, and home care. It also manufactures and sells elastomeric primary packaging components. It operates through three segments, which include the Pharma segment, Beauty segment, and Closures segment. The Pharma segment is a supplier of nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and health care markets worldwide. The Beauty segment sells pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care, and home care markets. The Closures segment includes dispensing and non-dispensing solutions that enable product delivery without removal of the cap and are used across multiple consumer end markets.